Register to join the Life Sciences Community

Register

Group

Identifying new potential risks for a products safety profile is at the heart of all PV activities.

Group

DAY 1 (1:30 PM ET) What is your biggest barrier to automating signal detection?

Baljit Klear-Oracle
edited Apr 19, 2022 2:30PM in Social Groups

Identifying new potential risks for a products safety profile is at the heart of all PV activities. But a product's safety profile is rarely static due to increased exposure, new or untested drug-drug interaction and pharmacogenetic variations, to name a few. The industry needs to move from manual traditional methods to more automated quantitative methods.

What is your biggest barrier to automating signal detection?

Select your top activity from the options below, or add as a comment.

Join us at 1:30PM–2:30PM ET for a lively panel discussion on The future of signaling.

Not yet registered for Health Sciences Connect 2022? Register here.

DAY 1 (1:30 PM ET) What is your biggest barrier to automating signal detection? 0 votes

Lack of a centralized system to track and manage signals
0%
Lack of flexibility with current tools to customise automation based on specific processes and procedures to meet local and global needs
0%
Inaccuracy of available algorithms leading to missing signals or too many false positives
0%
The change management required is too much for my organization
0%
Other - please specify in comments
0%

Any questions or feedback? Please contact us

Send email